# RNS System RESPONSE Study

> **NCT04839601** · NA · TERMINATED · sponsor: **NeuroPace** · enrollment: 9 (actual)

## Conditions studied

- Epilepsy
- Partial Seizure
- Neurostimulator; Complications
- Drug Resistant Epilepsy
- Focal Epilepsy

## Interventions

- **DEVICE:** RNS System

## Key facts

- **NCT ID:** NCT04839601
- **Lead sponsor:** NeuroPace
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-10-27
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-05-01
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Inadequate Enrollment
- **Last updated:** 2025-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04839601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04839601, "RNS System RESPONSE Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04839601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*